Subscribe to RSS
DOI: 10.1055/a-2708-5136
Impact of Maternal Obesity on Neonatal TSH Levels: A Prospective Study on the Influence of BMI
Authors

Abstract
Objective
Thyroid hormones are crucial for fetal growth, especially the development of the central nervous system. The impact of maternal obesity on neonatal thyroid-stimulating hormone (TSH) levels, however, remains underexplored. This study aimed to evaluate the influence of maternal body mass index (BMI) on neonatal TSH (nTSH) levels.
Study Design
A prospective observational study was conducted involving 934 newborns with a gestational age greater than 35 weeks, born between July 2021 and January 2022. nTSH levels were measured from capillary blood samples obtained during routine congenital hypothyroidism screening. Maternal data, including age, pre-pregnancy BMI, weight gain during pregnancy, and thyroid function, were collected.
Results
The mean maternal BMI was 24 ± 4 kg/m2, and the mean nTSH level was 2 ± 2.7 mIU/L. No significant difference in nTSH levels was observed between infants of mothers with BMI ≥25 and BMI <25 (p = 0.069). When mothers were categorized into five BMI groups, the only significant difference observed between the groups was in weight gain during pregnancy (p = 0.001). Additionally, a positive correlation between maternal BMI and neonatal birth weight, height, and head circumference was observed. A weak positive correlation between maternal weight gain and nTSH levels (r = 0.204, p = 0.001) was also noted.
Conclusion
Our study indicates a potential relationship between maternal obesity and nTSH levels, suggesting that maternal BMI may influence neonatal thyroid function.
Key Points
-
There is a potential relationship between maternal obesity and neonatal TSH levels.
-
Maternal BMI and weight gain might influence neonatal thyroid function.
-
The study emphasizes the need for close monitoring of pregnant women with obesity.
Keywords
maternal BMI - neonatal TSH - neonatal thyroid function - gestational weight gain - pregnancy outcomesPublication History
Received: 06 February 2025
Accepted: 23 September 2025
Article published online:
08 October 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Léger J, Delcour C, Carel JC. Fetal and neonatal thyroid dysfunction. J Clin Endocrinol Metab 2022; 107 (03) 836-846
- 2 Boelen A, Zwaveling-Soonawala N, Heijboer AC, van Trotsenburg ASP. Neonatal screening for primary and central congenital hypothyroidism: is it time to go Dutch? Eur Thyroid J 2023;12(4):e230041.
- 3 Rodríguez Sánchez A, Chueca Guindulain MJ, Alija Merillas M. et al. Diagnóstico y seguimiento de los pacientes con hipotiroidismo congénito diagnosticados por cribado neonatal [Diagnosis and follow-up of patients with congenital hypothyroidism detected by neonatal screening]. An Pediatr (Engl Ed). 2019; 90 (04) 250.e1-250.e8
- 4 Rose SR, Wassner AJ, Wintergerst KA. et al; Section on Endocrinology Executive Committee, Council on Genetics Executive Committee. Congenital hypothyroidism: screening and management. Pediatrics 2023; 151 (01) e2022060420
- 5 Kim J, Ayabe A. Obesity in pregnancy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; August 8, 2023
- 6 Reed J, Case S, Rijhsinghani A. Maternal obesity: perinatal implications. SAGE Open Med 2023; 11: 20 503121231176128
- 7 Neal K, Ullah S, Glastras SJ. Obesity class impacts adverse maternal and neonatal outcomes independent of diabetes. Front Endocrinol (Lausanne) 2022; 13: 832678
- 8 Njagu R, Adkins L, Tucker A. et al. Maternal weight gain and neonatal outcomes in women with class III obesity. J Matern Fetal Neonatal Med 2022; 35 (03) 546-550
- 9 Satpathy HK, Fleming A, Frey D, Barsoom M, Satpathy C, Khandalavala J. Maternal obesity and pregnancy. Postgrad Med 2008; 120 (03) E01-E09
- 10 Gebes O, Kale İ, Gebes TB, Muhcu M. Investigation of serum cartonectin concentrations in pregnant women with gestational diabetes mellitus; a prospective non-interventional cohort study. Gynecol Obstet Reprod Med 2024; 30 (01) 33-38
- 11 Kalk P, Guthmann F, Krause K. et al. Impact of maternal body mass index on neonatal outcome. Eur J Med Res 2009; 14 (05) 216-222
- 12 Sebastián Manzanares G, Angel Santalla H, Irene Vico Z, López Criado MS, Alicia Pineda L, José Luis Gallo V. Abnormal maternal body mass index and obstetric and neonatal outcome. J Matern Fetal Neonatal Med 2012; 25 (03) 308-312
- 13 D'Souza R, Horyn I, Pavalagantharajah S, Zaffar N, Jacob CE. Maternal body mass index and pregnancy outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol MFM 2019; 1 (04) 100041
- 14 Liu L, Ma Y, Wang N, Lin W, Liu Y, Wen D. Maternal body mass index and risk of neonatal adverse outcomes in China: a systematic review and meta-analysis. BMC Pregnancy Childbirth 2019; 19 (01) 105
- 15 Yurtcu E, Mutlu S, Ozkaya E. The effects of pre-pregnancy body mass index and weight gain during pregnancy on perinatal outcomes: a retrospective cohort study. Gynecol Obstet Reprod Med 2022; 28 (01) 16-22
- 16 Kahr MK, Antony KM, DelBeccaro M, Hu M, Aagaard KM, Suter MA. Increasing maternal obesity is associated with alterations in both maternal and neonatal thyroid hormone levels. Clin Endocrinol (Oxf) 2016; 84 (04) 551-557
- 17 Pop VJ, Biondi B, Wijnen HA, Kuppens SM, Lvader H. Maternal thyroid parameters, body mass index and subsequent weight gain during pregnancy in healthy euthyroid women. Clin Endocrinol (Oxf) 2013; 79 (04) 577-583
- 18 Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol 2010; 316 (02) 165-171
- 19 Özer Y, Anık A, Sayılı U. et al. High frequency of transient congenital hypothyroidism among infants referred for suspected congenital hypothyroidism from the Turkish National screening program: thyroxine dose may guide the prediction of transients. J Endocrinol Invest 2024; 47 (09) 2213-2224
- 20 Weir CB, Jan A. BMI Classification Percentile and Cut Off Points. In: StatPearls. Treasure Island (FL): StatPearls Publishing; June 26, 2023
- 21 Lee J, Lee NK, Moon JH. Gestational diabetes mellitus: mechanisms underlying maternal and fetal complications. Endocrinol Metab (Seoul) 2025; 40 (01) 10-25
- 22 Friis T, Bergman L, Hesselman S. et al. Gestational hypertension, preeclampsia, and eclampsia and future neurological disorders. JAMA Neurol 2025; 82 (02) 142-151
- 23 Pearce EN. Management of hypothyroidism and hypothyroxinemia during pregnancy. Endocr Pract 2022; 28 (07) 711-718
- 24 Hojeij B, Rousian M, Sinclair KD, Dinnyes A, Steegers-Theunissen RPM, Schoenmakers S. Periconceptional biomarkers for maternal obesity: a systematic review. Rev Endocr Metab Disord 2023; 24 (02) 139-175
- 25 Mosso L, Martínez A, Rojas MP. et al. Early pregnancy thyroid hormone reference ranges in Chilean women: the influence of body mass index. Clin Endocrinol (Oxf) 2016; 85 (06) 942-948
- 26 Torun Ö, Dut R, Aydan Sağlam Z, Cömert S. The effects of maternal weight-gain during pregnancy on neonatal TSH results. JGON 2022; 19 (04) 1500-1505
- 27 Zhou B, Chen Y, Cai WQ, Liu L, Hu XJ. Effect of gestational weight gain on associations between maternal thyroid hormones and birth outcomes. Front Endocrinol (Lausanne) 2020; 11: 610
- 28 Herbstman J, Apelberg BJ, Witter FR, Panny S, Goldman LR. Maternal, infant, and delivery factors associated with neonatal thyroid hormone status. Thyroid 2008; 18 (01) 67-76
- 29 Kuppens SM, Kooistra L, Wijnen HA. et al. Neonatal thyroid screening results are related to gestational maternal thyroid function. Clin Endocrinol (Oxf) 2011; 75 (03) 382-387
- 30 Sert UY, Celik HK, Karakaya BK, Caglar AT, Erdogan G, Engin-Ustun Y. The impact of first trimester TSH level on fetal growth and post-term pregnancy. Fetal Pediatr Pathol 2022; 41 (04) 584-591
- 31 Krishna B, Dhas PK, Ganesh V. Linking serum leptin and TSH among metabolic syndrome patients with and without hypothyroidism. Bioinformation 2025; 21 (01) 6-10